These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26261770)

  • 1. Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function.
    Reeves EP; McCarthy C; McElvaney OJ; Vijayan MS; White MM; Dunlea DM; Pohl K; Lacey N; McElvaney NG
    World J Crit Care Med; 2015 Aug; 4(3):179-91. PubMed ID: 26261770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2000; (2):CD001506. PubMed ID: 10796798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulized hypertonic saline decreases IL-8 in sputum of patients with cystic fibrosis.
    Reeves EP; Williamson M; O'Neill SJ; Greally P; McElvaney NG
    Am J Respir Crit Care Med; 2011 Jun; 183(11):1517-23. PubMed ID: 21330456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V
    Cochrane Database Syst Rev; 2003; (1):CD001506. PubMed ID: 12535409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertonic saline in treatment of pulmonary disease in cystic fibrosis.
    Reeves EP; Molloy K; Pohl K; McElvaney NG
    ScientificWorldJournal; 2012; 2012():465230. PubMed ID: 22645424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale for hypertonic saline therapy for cystic fibrosis lung disease.
    Tarran R; Donaldson S; Boucher RC
    Semin Respir Crit Care Med; 2007 Jun; 28(3):295-302. PubMed ID: 17562499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE; Godovchik JE; Donn KH; Busick DR; Goralski J; Locke LW; Markovetz MR; Myerburg MM; Muthukrishnan A; Weber L; Lacy RT; Pilewski JM
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.
    Boucher RC
    Annu Rev Med; 2007; 58():157-70. PubMed ID: 17217330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA; McDonald V; Jones AP
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001506. PubMed ID: 16034863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Cystic Fibrosis Lung Disease from Childhood to Adulthood: Neutrophils, Neutrophil Extracellular Trap (NET) Formation, and NET Degradation.
    Khan MA; Ali ZS; Sweezey N; Grasemann H; Palaniyar N
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30813645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008816. PubMed ID: 28146603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for airway surface dehydration as the initiating event in CF airway disease.
    Boucher RC
    J Intern Med; 2007 Jan; 261(1):5-16. PubMed ID: 17222164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Use Of Inhaled Hypertonic Saline In Children And Adolescents With Cystic Fibrosis: Experience From A Tertiary Care Center In A Low And Middle Income Country.
    Aziz DA; Shahid S; Alam A; Aziz N; Mir F
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(3):S686-S690. PubMed ID: 36414591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001506. PubMed ID: 19370568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled medications in cystic fibrosis beyond antibiotics.
    Sepe A; Villella VR; Cimbalo C; Castaldo A; Nunziata F; Corcione A; Bona G; Maiuri L; Raia V
    Minerva Pediatr; 2019 Aug; 71(4):371-375. PubMed ID: 30761821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPAP has no effect on clearance, sputum properties, or expectorated volume in cystic fibrosis.
    Aquino ES; Shimura F; Santos AS; Goto DM; Coelho CC; de Fuccio MB; Saldiva PH; Lorenzi-Filho G; Rubin BK; Nakagawa NK
    Respir Care; 2012 Nov; 57(11):1914-9. PubMed ID: 22417659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of hypertonic saline inhalation for cystic fibrosis.
    Elkins M; Dentice R
    Cochrane Database Syst Rev; 2012 Feb; (2):CD008816. PubMed ID: 22336853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Bacterial Secretion Systems in the Virulence of Gram-Negative Airway Pathogens Associated with Cystic Fibrosis.
    Depluverez S; Devos S; Devreese B
    Front Microbiol; 2016; 7():1336. PubMed ID: 27625638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dornase alfa for cystic fibrosis.
    Yang C; Chilvers M; Montgomery M; Nolan SJ
    Cochrane Database Syst Rev; 2016 Apr; 4():CD001127. PubMed ID: 27043279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.